Three capabilities: research and development, safety measures, and a diversified supply chain define why Amneal Pharmaceuticals can bring high-quality generics, specialty, and biosimilar medicines to market faster, safer, and more cost-efficiently.
Amneal is one of the largest growing generic pharmaceutical manufacturers in the United States, with a broad portfolio of more than 250 pharmaceutical products providing patients with affordable, high-quality medicines. The team develops and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a broad range of therapeutic categories. Many generics represent difficult-to-manufacture products or products with a high barrier-to-entry, such as oncologics, anti-infectives, and supportive care to healthcare providers.
Amneal’s specialty business offers neurologists, movement disorder specialists, endocrinologists, and primary care physicians a portfolio in core therapeutic categories, including central nervous system disorders, endocrinology, parasitic infections, and other therapeutic areas.
Pharmacies and healthcare institutions throughout the U.S. and Puerto Rico know that Amneal Pharmaceutical means an unwavering commitment to quality, service, and value.
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) is an integrated specialty pharmaceutical company powered by a robust U.S. generics business and a growing branded business. Together, our team is working to build one of the most dynamic pharmaceutical companies in our rapidly changing industry.
Marti Jones brings more than 20 years of integrated communications experience from world-renowned organizations. Marti’s career has grown from raising awareness and funds for the American Red Cross before and after 9/11 to leading strategy for brands such as Mayo Clinic, Duke Health, and M Health Fairview, which included communications for change management and COVID-19. Marti's messaging portfolios are supported by her academic background and proven methodology, as she taught writing at the University of Minnesota and honed her craft at UnitedHealth, UCare, and RXinsider, Revel Health and Hill and Knowlton. Marti received her master’s degree in public affairs and administration from George Washington University and Bachelor of Arts degrees in communications and psychology from Augustana University.
This post is related to:
Generics, Brand Name, Biotech
